This study is in progress, not accepting new patients
A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)
Cytomegalovirus (CMV)-Positive Recipients Allogeneic, Hematopoietic Cell Transplant (HCT) ASP0113 Cytomegalovirus (CMV) Hematopoietic Cell Transplant (HCT)
Lead Scientist at UCSF
- Aaron Logan
Dr. Aaron Logan is an Associate Professor of Clinical Medicine at the University of California, San Francisco (UCSF). His clinical practice focuses on the management of patients with acute leukemias, myelodysplastic syndrome, aplastic anemia and hemophagocytic lymphohistiocytosis. Dr. Logan also runs a research laboratory and is director of the Hematologic Malignancies Tissue Bank at UCSF.
- in progress, not accepting new patients
- Start Date
- Completion Date
- Astellas Pharma Global Development, Inc.
- Phase 3
- Study Type
- Last Updated